New hope for multiple sclerosis sufferers

October 23, 2008

Research indicates drug not only stops the disease from advancing but may also restore lost function in many patients

A drug which was developed in Cambridge and initially designed to treat a form of leukaemia has also proven effective against combating the debilitating neurological disease multiple sclerosis (MS).

The study, led by researchers from the University of Cambridge, has found that alemtuzumab not only stops MS from advancing in patients with early stage active relapsing-remitting multiple sclerosis (RRMS) but may also restore lost function caused by the disease. The findings were published today in the New England Journal of Medicine.

Alemtuzumab has a long connection with Cambridge, England. In 1984, Cambridge scientist Cesar Milstein was awarded the Nobel Prize for Physiology or Medicine, jointly with George Kohler, for inventing the technology to make large quantities of a desired type of monoclonal antibody. Further work in Cambridge, by Herman Waldmann and Greg Winter, led to the production of the first humanised monoclonal antibody for use as a medicine, Campath-1H, now known as alemtuzumab. It has been licensed for the treatment of chronic lymphocytic leukaemia, and has also been tested in several diseases where the immune system is overactive, such as multiple sclerosis.

The new study, which was funded by Genzyme and Bayer Schering Pharma AG, Germany , found that alemtuzumab reduces the number of attacks experienced by people with relapsing-remitting multiple sclerosis by 74 per cent over and above that achieved with interferon beta-1a, one of the most effective licensed therapies for similar cases of MS. More importantly, alemtuzumab also reduced the risk of sustained accumulation of disability by 71 per cent compared to interferon beta-1a.

Additionally, the investigators showed that many individuals in the trial who received alemtuzumab recovered some of their lost functions and so were less disabled after three years than at the beginning of the study, in contrast to worsening disability in the interferon beta-1a treated patients. These findings suggest that alemtuzumab may allow damaged brain tissue to repair, enabling the recovery of neurologic functions lost following poor recovery from previous MS attacks.

The new research shows that alemtuzumab is a much more effective treatment for early-stage RRMS than the currently approved drug interferon beta-1a. However, as the study was a Phase 2 clinical trial, additional research will need to be conducted before the drug is considered for approval in the treatment of MS.

"Alemtuzumab is the most promising experimental drug for the treatment of multiple sclerosis, and we are hopeful that the Phase 3 trials will confirm that it can both stabilize and allow some recovery of what had previously been assumed to be irreversible disabilities," says the principal investigator Alastair Compston, Professor of Neurology and the Head of the Department of Clinical Neurosciences at the University of Cambridge.

Multiple sclerosis is an autoimmune disease which is caused by the body's immune system attacking nerve fibres and their protective insulation, the myelin sheath, in the central nervous system. This damage prevents the nerves from 'firing' properly, and then leads to their destruction, resulting in physical and intellectual disabilities. Alemtuzumab works by destroying one population of white blood cell (lymphocytes) and, by shutting down the immune system, inhibits the damage to brain tissue that occurs in MS.

"The ability of an MS drug to promote brain repair is unprecedented. We are witnessing a drug which, if given early enough, might effectively stop the advancement of the disease and also restore lost function by promoting repair of the damaged brain tissue," says Dr Alasdair Coles, University Lecturer at the Department of Clinical Neurosciences, University of Cambridge who coordinated many aspects of the study.

The main side effect of treatment is, paradoxically, that people can develop other autoimmune diseases as the immune system gradually recovers following exposure to alemtuzumab. During the trial, 20% of people treated with alemtuzumab developed an over- or under-active thyroid gland. Rarely (3%) people developed a low platelet count and were vulnerable to bleeding. This complication led to one fatality during the trial. Although potentially very serious, this complication can be easily treated if recognised early.

The Phase 2 clinical study involved 334 patients who had been diagnosed with early-stage RRMS but had not previously been treated. Patients either received alemtuzumab (one of two dose levels intravenously for five days initially and three days of re-treatment 12 months later) or interferon beta-1a (given by injection three times per week). The patients were followed for three years to determine the efficacy of the treatments as well as the effect on the patients' disabilities.

MS affects almost 100,000 people in the United Kingdom, 400,000 in the United States and several million worldwide. Symptoms of the disease can include loss of physical skills, sensation, vision, bladder control, and intellectual abilities.

University of Cambridge

---

---

	Overcoming Multiple Sclerosis: An Evidence-Based Guide to Recovery by Professor George Jelinek (Author) A research-based approach to treating the devastating neurological condition multiple sclerosis, based on a combination of drug treatment and lifestyle modifications Multiple sclerosis (MS) is a serious, progressively disabling condition for which current medical treatment is not particularly effective and has many side effects, however, this guide provides a genuine alternative. Through an exhaustive, evidence-based analysis of medical research, the study concludes that MS is a disease largely determined by lifestyle factors. Showing that people with MS who modify their diet, their exercise habits, and other aspects of their lifestyle can stabilize the illness and potentially recover, these recommendations will change the lives of thousands of people with MS and support their loved...
	It's Not All in Your Head: Anxiety, Depression, Mood Swings, and Multiple Sclerosis by Patricia Farrell (Author) Multiple sclerosis can be a true roller coaster of emotions, and it’s critical that patients learn how to deal with these feelings — half of those living with MS warrant medical intervention for depression at some point. It's Not All in Your Head is a cognitive-behavioral approach to overcoming the depression, anxiety, and stress that goes hand-in-hand with this disease. Patricia Farrell helps individuals and their families better understand the effects that MS has on mood levels and anxiety, and she offers a plan of simple remediation in a self-help format. Farrell also provides a brief discussion of the diagnosis of MS and its effects on the many areas of an individual’s life, as well as an easy-to-understand explanation of the underlying neurology and why MS is now considered a...
	The First Year: Multiple Sclerosis: An Essential Guide for the Newly Diagnosed by Margaret Blackstone (Author), M.D. Saud A. Sadiq M.D. (Foreword) One of the most widely recommended guides to living with multiple sclerosis, now completely revised and updated, including the latest research, the most recent information on treatments (including the news on Tysabri®), and new tips for managing MS. Multiple sclerosis is as much a mystery as it is a disease, but this chronic and often disabling condition of the central nervous system affects over 400,000 people nationwide. From the moment of her diagnosis in 2000, Margaret Blackstone took charge and educated herself on every aspect of her condition. Now, as a "patient-expert," she guides those newly diagnosed step-by-step through their first year with MS. She provides crucial information about: The most up-to-date treatment options Effective alternative therapies Choosing the right...
	Managing Multiple Sclerosis Naturally: A Self-help Guide to Living with MS by Judy Graham (Author) A totally revised and updated edition of the first book to offer a holistic approach to slowing the progression of MS • Provides guidance on special diets and nutritional supplements, exercise, alternative therapies, and the effects of negative and positive thoughts on MS • Explains how to reduce toxic overload from mercury and chemicals • Includes life wisdom and coping strategies from others who suffer with MS Judy Graham is an inspiration. Diagnosed with multiple sclerosis when she was just 26 years old, 35 years later Judy Graham is still walking, working, and has successfully birthed and raised a son who is now an adult. In this totally revised and updated edition of her groundbreaking Multiple Sclerosis, first published in...
	Awkward Bitch: My Life with MS by Marlo Donato Parmelee (Author)
	Multiple Sclerosis For Dummies by Rosalind Kalb Ph.D. (Author), Nancy Holland RN EdD MSCN (Author), Barbara Giesser MD (Author), David L. Lander (Foreword) Being diagnosed with multiple sclerosis (MS) doesn’t have to mean your life is over. Everyone’s MS is different and no one can predict exactly what yours will be like.The fact is, lots of people live their lives with MS without making a full-time job of it.MS for Dummies gives you easy to access, easy to understand information about what happens with MS—what kinds of symptoms it can cause, how it can affect your life at home and at work, what you can do to feel and function up to snuff, and how you can protect yourself and your family against the long-term unpredictability of the disease. You'll learn:Why some people get MS and others don’tHow to make treatment and lifestyle choices that work for youWhat qualities to look for in a neurologist and in the rest of your healthcare...
	Coffee in the Cereal: The First Year with Multiple Sclerosis by Lorna J. Moorhead (Author) In the quirky, sassy voice that has made her popular on health Web sites and with the women of MS MOMS, Lorna Moorhead recounts the experience of her first year with multiple sclerosis with a vitality unique in the often gloomy world of personal medical histories.
	Healing Multiple Sclerosis: Diet, Detox & Nutritional Makeover for Total Recovery by Ann Boroch (Author), Ann Louise Gittleman (Foreword) Multiple Sclerosis can now be healed and this book shows you how. Though MS is widely believed to be incurable, Boroch's breakthrough treatment protocol can dramatically restore patients to health. This landmark book describes her own tumultuous journey with MS: • Her quest for a cure • Case histories of those who have triumphed over MS • The real causes of MS • How to develop a personal treatment plan • Everything you need to bring about recovery, including a detailed and effective self-help treatment protocol • Delicious recipes and recommended foods, with two weeks of sample menus • A five-week nutritional makeover, recommended supplements and a daily sample supplement schedule • A list of recommended products • User-friendly charts and resources
	Multiple Sclerosis: The Questions You Have, the Answers You Need by Ph.D. Rosalind C. Kalb (Editor) Multiple Sclerosis: The Questions You Have, the Answers You Need is the definitive guide for everyone concerned with the disease—those who have MS and those who share their lives with someone who has it. It covers a wide range of topics in an accessible question and answer format that allows people to easily find the information they need while providing a model of successful communication with healthcare providers. The contributors are leading authorities in all areas of multiple sclerosis management, who proffer expert answers to the most common questions about living with MS—medical, emotional, social, and economic – and represents a interdisciplinary approach to the disease. The book’s goal is to help those with MS and their families formulate questions to ask their...
	Cooking Well: Multiple Sclerosis: Over 75 Easy and Delicious Recipes for Nutritional Healing by Marie Courtier (Author), Vincent F. Macaluso MD (Foreword) Can practicing a healthy lifestyle, which includes a healthy diet, decrease Multiple Sclerosis symptoms? In the U.S. alone, approximately 400,000 people suffer from Multiple Sclerosis (MS). MS is an autoimmune disease that affects the central nervous system. There are a variety of symptoms of MS, and it affects people in different ways, but there is no cure. Eating well can help strengthen your body, and make living with the disease a little easier. Maintaining a low fat diet with foods containing anti-inflammatory properties can improve your well-being by decreasing your MS-related symptoms and flare-ups. Cooking Well: Multiple Sclerosis features over 100 recipes designed to improve daily functioning and aid in the treatment of this disease. Cooking Well:...